India’s Drug Watchdog DCGI Speeds Up Regulatory Overhaul; Single Window Clearance to Precede Central Drug Authority
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - India's drug regulatory body, the Drug Controller General of India, is set for a comprehensive overhaul of its regulatory and administrative functions
You may also be interested in...
M K Bhan, Secretary To India’s Department Of Biotechnology On Creating Indian Biopolis Akin To Singapore: An Interview With PharmAsia News
Dr. Maharaj Kishan Bhan, secretary to the department of biotechnology, government of India, is perhaps the best known biotechnology scientist in the country. He is also known to have connected science and technology with the primary healthcare needs of India's rural population through many programs. Bestowed with a number of responsibilities, Bhan tells PharmAsia News he is working on a plan to change the Indian biotechnology landscape.
M K Bhan, Secretary To India’s Department Of Biotechnology On Creating Indian Biopolis Akin To Singapore: An Interview With PharmAsia News
Dr. Maharaj Kishan Bhan, secretary to the department of biotechnology, government of India, is perhaps the best known biotechnology scientist in the country. He is also known to have connected science and technology with the primary healthcare needs of India's rural population through many programs. Bestowed with a number of responsibilities, Bhan tells PharmAsia News he is working on a plan to change the Indian biotechnology landscape.
India’s Central Drug Authority May Be Shelved; Four Zonal Authorities Mooted
Disseminated power appears to be the goal, but would the system require four times the paperwork?